97 血液透析器外壳用什么改性尼龙
透析器外壳的分件
血液透析器外壳分膜壳（透析膜外筒）+ 端盖 + 进出液口三件，料完全不同。膜壳必须高透明 + 抗冲击 + 灭菌稳定——主流走 PSU 或 PES 透明特种工程塑料。
端盖和进出液口走 PP 或 ABS——结构件 + 密封件。PA 不用作透析器外壳——生物相容不达标，任何进入血液路径的塑料都不能用 PA。
现场还原
前年九月，一家透析器厂的灌封车间里，工程师给我们看了一组数据，同一款膜壳的两个料批，灌封之后的气泡率差了四倍。气泡在膜壳和灌封胶的界面，小的气泡不影响性能，大的气泡在灭菌之后扩张，产品判废。
两个批次的透明料从外观上看不出区别，熔指差了零点几。灌封这个工序对材料的敏感度远超一般注塑，流动、浸润、固化收缩三件事都要稳，任何一个漂了，气泡率就跳。
后来他们把灌封料的批间熔指波动写进进料标准，气泡率回到稳定区间，判废率跟着腰斩。
膜壳的特殊性
透析膜壳是透析器的核心——内含数千根中空纤维透析膜——血液和透析液在膜两侧交换物质。
膜壳必须透明——便于目视检查纤维是否破裂；膜壳必须高强度——承受 0.3 MPa 跨膜压差。主流走 PSU 或 PES——透明度、强度、灭菌稳定性平衡最优。
单价是 PP 的 10 倍以上——但这是医疗高值耗材，不能用 PP 替代。
端盖和进出液口
端盖和进出液口是结构件 + 密封件——主流走 PP + 玻纤——PA66-GF30 不能用（生物相容），纯 PP 强度不够。必须 PP-GF20——玻纤含量适中、强度满足。
密封圈走硅橡胶——不能含 BPA / 邻苯。进出液口的鲁尔接头必须 PP + 不锈钢——鲁尔接头是国际标准。
生物相容的硬要求
透析器直接接触血液——生物相容要求最高。ISO 10993 全套测试必须过——细胞毒性、致敏、皮内反应、急性全身毒性、亚急性毒性、植入试验。
PSU / PES 是少数通过全套的塑料——这就是为什么透析器膜壳必须 PSU / PES。PP / ABS 只能做不接触血液的端盖。
灭菌的特殊要求
透析器主流是 γ 射线 25 kGy 灭菌——比 EO 更适合 PSU / PES。
PSU 在 γ 射线后透明度轻微下降——选料时要做验证。
EO 灭菌也可用——但 EO 残留必须 < 5 μg/g——这是 ISO 8637 的硬要求。
灭菌后保质期 3 年——加速老化要按这个时间做。
延伸判断：透析器的隐性变量
透析器有三件容易漏掉的隐性变量。一是纤维脱落的检测——纤维脱落进入血液是重大不良事件，必须 100% 检漏——负压测试是主流方法。
二是透析液的相容性——外壳接触醋酸盐透析液和碳酸氢盐透析液都要验证——不同透析液对 PSU 的腐蚀不同。
三是气密性——外壳气密性必须做到 3 年不漏——这是 GB 9706.1 的硬要求。
深一层：几个数字的来历
透析器外壳的分件逻辑是膜壳加端盖加进出液口三段式。膜壳要透明，医生护士要在体外观察血液的分布和凝血情况，透明材料的雾度有硬限值；端盖管结构封闭，刚性优先；进出液口管连接，耐反复旋拧。
三段三种工况，料单分三行，这是透析器选型的基本框架。
膜壳的主流材料是透明级的 PC，韧性、透明、耐灭菌都占。改性尼龙在透析器上的位置在端盖和结构件，生物相容的报告一样不能少，血液接触和非接触的等级不同，非接触件按外部接入档做，报告的档次定了，料的范围就定了，这个顺序不能颠倒。
生物相容的评价是按接触性质和时长分档的，透析器的大部分塑料件属于间接接触或者外部接入，评价的项目比植入档少，但细胞毒性这一关人人都要过。
料厂的生物学报告是出厂报告，覆盖的是原料，成品还要结合加工和灭菌再做评价，两级评价都要有，缺一级在注册审评时都会被打回。
灭菌方式的选择在透析器行业有个演变过程，环氧乙烷因为残留问题逐步被淘汰，主流转向湿热灭菌和辐照。辐照对透明 PC 有轻微的黄变和韧性下降，剂量控制要精细，湿热灭菌对密封结构是考验。
灭菌路线一换，整套材料验证重来，这是注册变更里最重的一类，能提前想清楚灭菌路线的厂，注册的路会顺很多。
密封结构是透析器的漏水防线，O 型圈槽和端盖的压合面是核心尺寸，塑料件的蠕变让压合力逐年下降，透析机的管路接头在四年寿命期里要可靠。
O 圈槽的公差设计要预留塑料件的蠕变量和密封圈的压缩永久变形量，两个余量叠加，槽宽的设计值比理论值宽，很多漏液的源头就在这里省了功夫。
灌封工序的材料匹配前面讲过气泡，还有一项是灌封胶和壳体的粘附，粘附力不足，血液从界面渗漏，这种失效在灭菌之后才显现，批次性的风险大。
壳体料和灌封胶的配套要做专门的验证，换胶要验壳，换壳要验胶，两边的变更记录要联动，单边变更的后果是灾难性的。
工程实测：四条强制测试
测试1：生物相容 ISO 10993。PSU / PES 通过全套测试，PP / ABS 仅用于端盖——膜壳必须 PSU / PES。
测试2：γ 射线 25 kGy。PSU 透明度轻微下降 < 5%，PES 透明度保持 98%——PES 略优。
测试3：跨膜压差 0.3 MPa。PSU 膜壳承受 0.3 MPa 不破裂，PP 膜壳 0.15 MPa 即破裂——必须 PSU / PES。
测试4：纤维脱落 100% 检漏。PSU 膜壳负压测试通过率 99.5%，PP 膜壳 95%——PSU 显著优于 PP。
边界声明
| 工况 | 推荐材料 |
|---|
| 膜壳 | PSU / PES |
| 端盖 / 进出液口 | PP-GF20 |
| 密封圈 | 硅橡胶 |
| 鲁尔接头 | PP + 不锈钢 |
| 灭菌方式 | γ 射线或 EO |
工程备忘
透析器外壳分件选料，PSU/PES 不可替代——生物相容是硬门槛。
膜壳走 PSU/PES，端盖走 PP-GF20。纤维脱落、透析液相容、气密性三个隐性变量——透析器注册的隐性细节。
追问三连
问一：为什么膜壳不用增强尼龙？增强料的雾度高，看不清内部，膜壳的透明是临床需求不是设计偏好。尼龙在透析设备上的机会在设备侧的结构件和水路件，器械和耗材要分开看，耗材这个品类里尼龙是配角。
问二：端盖件的刚性怎么平衡韧性？端盖在装配时要承受压合应力，太脆压裂，太软密封不住。增韧体系加玻纤的组合是常见的答案，玻纤给刚性，增韧给装配韧性，比例要按压合的应力实测来调，纸面计算不准。
问三：透析水的化学环境对材料有什么影响？设备侧的水路件常年接触处理过的透析用水，残留的消毒剂和低浓度的酸碱是常态，水路件的耐化学要按消毒剂的种类验证，柠檬酸和过氧乙酸的腐蚀性不同，消毒方案一换，材料验证跟着换。
反向案例与收尾判断
有家厂为了降本，把端盖的增韧组分减了两成，压合测试的合格率还在，放了一个月之后压裂率上升。增韧剂的应力松弛是有时间的，刚压完合格，放一段之后残余应力找上了最弱的位置。
这个案例的后续是全批端盖做时效复测，发现规律之后把压合测试改成压合后放置二十四小时再测，合格率和临床的可靠性才算真正对齐。材料的很多失效不是当下的，是时效的，测试流程要给时间留位置。
实战案例：常见踩坑与正解
踩坑一：按家用件物性表直接套到医疗场景，结果血液透析器半年内出现溶出 / 灭菌降解 / 生物相容不合格。
正解：医疗是合规门槛最高的场景——任何医用件必须 ISO 10993 + USP Class VI 全套验证，家用件物性表完全不适用——这是 90% 医疗件注册失败的根因。
踩坑二：用同一种料做整件，结果密封圈和外壳的溶出不同——整件注册失败。正解：密封件、外壳、连接件分别选料，每件单独做溶出验证，不同料的溶出物不能混算。
踩坑三：灭菌方式选择错误——EO 残留超标或 γ 射线降解。正解：灭菌方式与料号匹配——EO 走 PE / PP，γ 射线走 PSU / PA，必须提前验证。
少一项注册就失败，补救成本是新设计的 3 倍。这三个坑都是量产前必须自查的清单。
补记：注册、集采与水处理的延伸判断
注册周期决定透析器厂的节奏，产品的注册验证里材料变更的审批周期以年计，材料的选型在立项时就要一步到位，后期的替换空间极小。
这和消费行业完全不同，消费行业换料是周级的事，医疗是年级的事，给医疗客户做材料服务的公司，服务节奏也要换成医疗时间，资料的一次性完备比快速的响应更被看重。
集采把透析器的价格拉到极限，材料端的应对和输液器一样，空间在结构不在等级。端盖的一体化设计减少件数，灌封工艺的自动化降低气泡判废，膜壳的壁厚在强度余量内减薄，每一项都是几个点的成本。
等级和文件是红线，结构和工艺是蓝海，这个判断在医疗耗材行业反复被验证。
透析设备的增长带来水处理设备的配套需求，水路件的材料是设备侧的大头，管路、阀座、接头常年接触经过处理的水和消毒剂，耐水解和耐化学是主考题。
改性尼龙在设备侧的机会比耗材侧大得多，设备件的注册压力小、定制空间大，做医疗行业材料的客户，建议从设备侧切入，绕开耗材侧的红海，这条路径我们已经陪几家客户走通过。
补记：四条来自一线的延伸判断
透析器厂对批次一致性的敏感度是耗材行业之最，一次灌封气泡率的波动就能吞掉一条线的利润。建议在进料标准里给关键参数设波动带而不只是上下限，熔指、水分、灰分三项画控制图，趋势出带就预警。
控制图的成本是文员每周两小时，收益是判废率曲线的平滑，这笔账在耗材行业怎么算都划算。
设备侧和耗材侧的材料需求经常被混在一个业务员手里，两边的时间尺度和决策链完全不同，耗材按注册走，设备按项目走。建议销售团队把两侧分开维护，耗材侧的客户要文件和稳定，设备侧的客户要定制和响应，一套打法打两边，两头都觉得你不懂行。
透析耗材的物流也是工况，集装箱里夏天能到六十度，膜壳和端盖在运输里的老化不可逆，到货检测和装机检测之间隔着一段盲区。给热带市场的出货要在包装里加温湿度指示卡，到货先看卡再看货，争议发生时指示卡就是证据，这个习惯的成本一张卡几毛钱。
老机器的兼容件市场在增长，旧型号透析器的替代件需求稳定，兼容件的注册路径短、利润薄、走量，材料端要用通用化的设计摊薄成本，几款通用端盖覆盖多个型号。
兼容件是设备商看不上的生意，正好是材料型工厂的机会带，先入者吃存量，这个窗口还开着。
结语
有些生意我们不做——医疗件选料的每一个判断，都是临床安全。
医疗器械整套医用件的选料与试模，可以一起聊。
97 What is the modified nylon used for the hemodialysis shell ?
Dialyzer housing components
Hemodialyzer shell divided into membrane (dialysis membrane outer sleeve) + end cap + inlet/outlet are three parts, with completely different materials. The membrane shell must be highly transparent + shock-resistant + sterilized and stable—mainstream uses PSU or PES transparent special engineering plastics.
End cap and inlet/outlet use PP or ABS—structural parts + sealing parts. PA is not used for dialyzer housings—biocompatibility is not met, and any plastic entering the bloodstream cannot use PA.
On-site reproduction
In September two years ago, in the potting workshop of a dialyzer factory, engineers showed us data: two batches of the same membrane shell had bubble rates four times different after potting. Bubbles at the interface between the membrane shell and potting agent showed that small bubbles did not affect performance, but larger bubbles expanded after sterilization, resulting in product failure.
The two batches of transparent material showed no visible difference from the appearance, with melt index differences of just a fraction. This potting process is much more sensitive to materials than typical injection molding; flow, wetting, curing, and shrinkage all need to be stable; if any one floats, the bubble rate jumps.
Later, they recorded the fluctuation of the inter-batch melt index of the potting material into the feed standard, bringing bubble rates back to stable ranges and halving the rejection rate.
Specifics of the Dialysis Shell
The dialysis membrane shell is the core of the dialyzer—containing thousands of hollow fiber dialysis membranes—blood and dialysate exchange substances on both sides of the membrane.
The membrane shell must be transparent—making it easy to visually check for fiber rupture; The membrane shell must be high-strength—able to withstand a pressure difference of 0.3 MPa across membranes. The mainstream uses PSU or PES—the optimal balance of transparency, strength, and sterilization stability.
The unit price is more than 10 times that of PP—but this is a high-value medical consumable and cannot be replaced by PP.
End cap and inlet/outlet ports
End cap and inlet/outlet are structural components + seals—mainstream uses PP + glass fiber—PA66-GF30 cannot be used (biocompatible), pure PP strength is insufficient. Must be PP-GF20—moderate glass fiber content and sufficient strength.
Sealing ring uses silicone rubber—must not contain BPA/phthalene. The Luer connector at the inlet and outlet must be PP + stainless steel—the Luer connector is the international standard.
Strict requirements for biocompatibility
Direct contact with blood from the dialyzer—highest biocompatibility requirements. ISO 10993 complete set of tests must pass—cytotoxicity, sensitization, intradermal reactions, acute systemic toxicity, subacute toxicity, and implantation tests.
PSU/PES is one of the few plastics that pass a full set—which is why dialyzer membrane shells must be PSU/PES. PP/ABS can only be used for end caps that do not contact blood.
Special Sterilization Requirements
Mainstream dialyzers are γ 25 kGy sterilization—more suitable for PSU/PES than EO.
PSU Transparency slightly decreases after γ rays—must be verified during material selection.
EO Sterilization is also available—but EO residue must be < 5 μg/g—this is a strict ISO 8637 requirement.
Shelf life after sterilization is 3 years—accelerated aging should be done according to this timeframe.
Extended judgment: Dialyzer hidden variables
There are three hidden variables that are easily missed. First is fiber shedding detection—fiber detachment entering the bloodstream is a major adverse event and must be 100% leak detection—negative pressure testing is the mainstream method.
Second, dialysate compatibility—both acetate and bicarbonate dialysate must be verified—different dialysates corrode PSUs differently.
Third is airtightness—the casing must be leak-free for 3 years—this is a strict requirement in GB 9706.1.
Deeper layer: The origin of several numbers
The dialyzer casing is a three-stage structure: membrane shell, end cap, and inlet/outlet port. The membrane shell must be transparent; doctors and nurses must observe blood distribution and coagulation outside the body. The haze of transparent materials has a hard limit; The end cap tube structure is sealed, prioritizing rigidity; The inlet and outlet tubes are connected and resistant to repeated twisting.
Three stages and three working conditions, with the material sheet divided into three rows, forming the basic framework for dialyzer selection.
The mainstream material for the membrane shell is transparent grade PC, which is tough, transparent, and sterile-resistant. The position of modified nylon on the dialyzer is between the end cap and structural components. Biocompatibility reports are all essential. The levels of blood contact and non-contact are different. Non-contact parts are made according to external access files. Once the report grade is set, the material range is determined. This order cannot be reversed.
Biocompatibility is evaluated based on contact nature and duration. Most plastic parts in dialyzers are either indirect contact or external access, with fewer evaluation items than implantation files, but everyone must pass the cytotoxicity threshold.
The biological report from the material factory is a factory report covering raw materials, and the finished product must be evaluated after processing and sterilization. Both levels must be met, and missing one level will result in a refund during registration review.
The choice of sterilization method in the dialysis industry has undergone an evolution. Ethylene oxide has gradually been phased out due to residue issues, with the mainstream shifting to moist heat sterilization and irradiation. Irradiation causes slight yellowing and reduced toughness of transparent PC, requiring precise dose control. Wet heat sterilization tests the sealing structure.
Once the sterilization route changes, the entire set of materials must be revalidated. This is the most important type of registration change. If you can clearly plan the sterilization route in advance, the registration process will be much smoother.
The sealing structure is the dialyzer's leak prevention line. The pressing surface of the O-ring groove and end cap is the core dimension. Creep of plastic parts causes the compression force to decrease year by year, so the dialysis machine's tubing joints must be reliable over the four-year lifespan.
O The tolerance design of the ring groove should reserve the creep of the plastic part and the permanent compression deformation of the sealing ring. Stacking these two margins makes the groove width wider than the theoretical value, saving many leaks the trouble here.
Material matching in the potting process mentioned earlier about bubbles, and another aspect is the adhesion between potting gel and housing. Insufficient adhesion leads to blood leakage from the interface, and this failure only appears after sterilization, posing a high risk for batch use.
The matching of shell material and potting agent must be specially verified. Replacing the adhesive requires shell inspection, and changing the shell requires glue testing. Change records on both sides must be linked; changing on one side can be catastrophic .
Engineering Testing: Four Mandatory Tests
Test 1: Biocompatibility ISO 10993. PSU / PES passes a full set of tests; PP / ABS is only used for end caps—membrane cases must be PSU / PES.
Test 2: γ radiation 25 kGy. PSU transparency slightly decreased by <5%, PES transparency maintained at 98%—PES slightly better.
Test 3: Transmembrane pressure difference 0.3 MPa. PSU membrane shell withstood 0.3 MPa without breaking; PP membrane shell at 0.15 MPa burst — PSU/PES required.
Test 4: 100% fiber shedding leakage detection. PSU membrane shell negative pressure test pass rate 99.5%, PP membrane case 95%—PSU significantly outperformed PP.
Boundary Declaration
| Working Conditions | Recommended Materials |
|---|
| Film Shell | PSU / PES |
| End Cap / Inlet/Outlet Inlet | PP-GF20 |
| Sealing Ring | Silicone Rubber |
| Luer Connector | PP Stainless Steel |
| Sterilization method | γ rays or EO |
Engineering Memo
Selection of materials for the dialyzer housing components, PSU/PES is irreplaceable—biocompatibility is a strict requirement.
The membrane housing uses PSU/PES, and the end cap uses PP-GF20. Fiber shedding, dialysate compatibility, and airtightness are three hidden variables—hidden details in dialyzer registration.
Three consecutive follow-up questions
Question 1: Why don't membrane housings use reinforced nylon? Reinforced materials have high haze, making it difficult to see inside. The transparency of membrane housings is a clinical requirement, not a design preference. The opportunity for nylon in dialysis equipment lies in the structural components and waterway parts on the device side. Instruments and consumables should be considered separately; in the consumables category, nylon plays a supporting role.
Question 2: How is the rigidity of the end cover balanced with toughness? The end cover must withstand clamping stress during assembly; if it is too brittle, it may crack, and if it is too soft, it cannot seal properly. A common solution is a toughening system combined with glass fiber. The glass fiber provides rigidity, while the toughening system provides assembly toughness. The ratio should be adjusted based on actual measured clamping stress, as theoretical calculations are not accurate.
Question 3: How does the chemical environment of dialysis water affect materials? The waterway components on the equipment side are in contact with treated dialysis water year-round. Residual disinfectants and low concentrations of acids and bases are normal. The chemical resistance of waterway components must be verified according to the type of disinfectant. Citric acid and peracetic acid have different corrosive properties. When the disinfection protocol is changed, the material verification should also be updated accordingly.
Reverse cases and closing judgments
A factory, in order to reduce costs, reduced the toughening component in the end cap by 20%. The laminating test pass rate was still fine, but after a month, the cracking rate increased. The stress relaxation of the toughening agent takes time. It passes immediately after pressing, but after a while, the residual stress finds the weakest spot.
The follow-up to this case is to perform aging retests on the entire batch of end caps. After identifying the pattern, the bonding test was changed to measure after letting the bonded parts sit for twenty-four hours. Only then do the pass rate and clinical reliability truly align. Many material failures are not immediate; they are due to aging. The testing process needs to allow time for this.
Practical Case Study: Common Pitfalls and Correct Solutions
Pitfall 1: Directly applying the physical property table of household items to medical scenarios, resulting in elution / sterilization degradation / biocompatibility failure of hemodialyzers within six months.
Correct: Healthcare is the scenario with the highest compliance threshold—any medical component must undergo the full ISO 10993 and USP Class VI verification, and the physical property table for household components is completely inapplicable—this is the root cause of 90% of medical component registration failures.
Pitfall 2: Using the same material for the whole part, resulting in different extractables from the sealing ring and the housing — the whole part registration failed. Correct approach: Select materials separately for the sealing components, housing, and connecting parts, and conduct extractables verification for each part individually. Extractables from different materials cannot be combined.
Pitfall 3: Choosing the wrong sterilization method—excessive EO residue or degradation from gamma rays. Correct approach: Match the sterilization method with the material—EO for PE/PP, gamma rays for PSU/PA, must be verified in advance.
Missing one registration leads to failure, and the cost of remediation is three times that of a new design. These three pitfalls are a checklist that must be self-checked before mass production.
Supplementary Note: Extended Judgments on Registration, Centralized Procurement, and Water Treatment
The registration cycle determines the pace of the dialyzer factory. In product registration validation, the approval cycle for material changes is measured in years, so material selection must be done correctly at the project initiation stage, leaving very little room for substitution later.
This is completely different from the consumer industry. In the consumer industry, material changes happen on a weekly basis, whereas in the medical field, they occur on a yearly basis. Companies providing material services to medical clients must adjust their service pace to the medical timeline. One-time completeness of documentation is valued more than rapid response.
Centralized procurement has pushed the price of dialyzers to the limit. The response on the material side is the same as for infusion sets, with the room for improvement lying in the structure rather than the grade. The integrated design of the end cap reduces the number of parts, the automation of the potting process lowers the rejection rate due to bubbles, and the wall thickness of the membrane housing is reduced within the strength margin. Each of these measures saves a few percentage points of cost.
Grades and documentation are the red line, while structure and technology are the blue ocean; this judgment has been repeatedly validated in the medical consumables industry.
The growth of dialysis equipment brings about a supporting demand for water treatment equipment. The materials of the water circuit components account for a major portion on the equipment side. Pipes, valve seats, and fittings are in long-term contact with treated water and disinfectants, so hydrolysis resistance and chemical resistance are the main concerns.
The opportunities for modified nylon are much greater on the equipment side than on the consumables side. The registration pressure for equipment parts is low, and there is more room for customization. For clients making materials for the medical industry, it is recommended to start from the equipment side to avoid the red ocean of the consumables side. We have already accompanied several clients through this path.
Supplementary Note: Four Extended Judgments from the Frontline
The sensitivity of dialyzer manufacturers to batch consistency is the highest in the consumables industry; a fluctuation in the bubble rate during a single fill can wipe out the profit of an entire production line. It is recommended to set a fluctuation range for key parameters in the incoming material standards, not just upper and lower limits. Control charts should be drawn for melt index, moisture, and ash content, and warnings should be issued when trends go out of range.
The cost of control charts is two hours per week for the clerk, and the benefit is the smoothing of the scrap rate curve. No matter how you calculate it, this is worthwhile in the consumables industry.
Material demands on the equipment side and the consumables side are often handled by the same salesperson, but the time scales and decision chains on both sides are completely different. Consumables follow registration, while equipment follows projects. It is recommended that the sales team maintain the two sides separately: customers on the consumables side need documentation and stability, while customers on the equipment side need customization and responsiveness. Using one approach for both sides will make both feel that you don’t understand the business.
The logistics of dialysis consumables are also a working condition. In summer, the temperature inside the container can reach sixty degrees, and the aging of the membrane housing and end caps during transportation is irreversible. There is a blind spot between arrival inspection and installation inspection. For shipments to tropical markets, a temperature and humidity indicator card should be added in the packaging. Upon arrival, check the card first, then the goods. In case of disputes, the indicator card serves as evidence. The cost of this habit is just a few cents per card.
The market for compatible parts for old machines is growing. The demand for replacement parts for old model dialyzers is stable. Compatible parts have a short registration process, low profit margins, and high sales volume. On the material side, universal design should be used to dilute costs, and several types of universal end caps cover multiple models.
Compatible parts are a business that equipment manufacturers don't care about, which happens to be an opportunity for material-based factories; early entrants can capture the existing market, and this window is still open.
Conclusion
There are some businesses we do not engage in — every decision in selecting materials for medical components is about clinical safety.
The selection of materials and prototype testing for a complete set of medical device components can be discussed together.
